Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isotretinoin vs hCG in Males With Oligospermia and Azoospermia
NCT07481370Phase 2Enrolling by invitation
- Sponsor
- University of Nebraska
- Start
- Apr 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of isotretinoin in oligospermia, nonobstructive azoospermia (NOA), sponsored by University of Nebraska. Started Apr 2026; status: enrolling by invitation.
02
Drugs
isotretinoin
03
Conditions
oligospermianonobstructive azoospermia (NOA)
Beyond the preview
Go deeper on NCT07481370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07481370.